from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1317c/alkA

LFCtreatmentdescriptionclass of inhibitor

-0.475

Amikacinug/mL Amikacintranslation

-1.044

Cap5-10ug/mL Capreomycintranslation

-1.418

Rox10-50 ug/mL Roxithromycintranslation

-0.579

SM2-5 ug/mL Streptomycintranslation

-1.060

Tet5-10 ug/mL Tetracyclinetranslation

-0.304

Rif0.2-5ug/mL Rifampicintranscription

-0.404

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.445

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.458

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.016

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.087

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.209

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.173

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.027

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.302

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.315

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.074

Nigericin50 uM Nigericinrespiration

0.045

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-0.079

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.074

menadione6-10 ug/mL Menadionerespiration

0.522

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.349

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.281

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.279

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.431

NRP_1Non-replicating persistence stage 1dosRassociated

-0.454

Amp0.2mg/mL AmpicillincellWall

-0.551

Cephalexin20-100 ug/mL CephalexincellWall

-0.272

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.411

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.456

EMB10-20 ug/mL EthambutolcellWall

-0.217

Eta12-40 ug/mL EthionamidecellWall

-0.474

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.094

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.547

BZA0.12 mg/mL BenzamidearomaticAmides

0.226

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.135

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.486

H2O24 mM hydrogen peroxideDNAdamaging

2.426

Levo10 ug/mL LevofloxacinDNAdamaging

0.547

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.551

Novobiocin10 ug/mL NovobiocinDNAdamaging

3.380

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.568

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.591

Antimycin12.5-50 ug/mL Antimycin A?

-0.786

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.302

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.047

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.469

PA8240.2-2 ug/mL PA-824?

-1.007

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-1.373

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.094

Verapamil50 uM Verapamil?

0.122

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.124

methoxatin10-20 ug/mL Methoxatin?